Skip to content
Search

Latest Stories

New study suggests soup and shake diet can reverse diabetes

After adhering to the daily diet for three months and successfully maintaining their weight loss, patients were found to be free from symptoms and medication-free five years later

New study suggests soup and shake diet can reverse diabetes

A breakthrough study by Diabetes UK, called the Diabetes Remission Clinical Trial (DiRECT), has found that going on an 800-calorie-a-day “soup and shake” diet for three months can permanently reverse type 2 diabetes.

After adhering to the daily diet for three months and successfully maintaining their weight loss, patients were found to be free from symptoms and medication-free five years later.


This offers hope to over four million Britons who have the condition, that they can improve their life expectancy, put the condition into remission, and avoid potentially fatal complications.

The study also offers NHS staff a cheaper, drug-free method of treating type 2 diabetes. Patients will be prescribed the “soup and shake” diet which costs £1,100 per patient, The Sunday Times reported.

This revolutionary method of treatment is ground-breaking because it offers a possible cure and is available to patients through their GP.

Professor Roy Taylor, of Newcastle University, who led the study has stated that “the benefits of weight loss could be permanent and lifelong.”

The study confirms that the benefits of weight loss continue for the long term, proving for the first time that type 2 diabetes is reversible.

This finding gives patients hope that they can escape from their diabetes and, if they keep the weight off, they will remain healthy.

Professor Mike Lean of the University of Glasgow, who co-led the study, said, “This study has shown us that a substantial proportion of people can maintain sufficient weight loss to be free from the condition for up to five years.”

The study recruited 298 patients with type 2 diabetes through GP surgeries. In the initial study, 46% of those on the diet for three to five months were in remission one year later, with 36% in remission after two years.

The updated results show that 23% of those in remission after two years were still free of symptoms five years later.

This group, who were in remission, had an average weight loss of about 9kg (1st 6lb) at the five-year point.

If people put a significant amount of weight back on over the five-year period, the diabetes symptoms returned. However, they were still less likely to develop complications requiring hospital admission than a control group who did not follow the three-month “soup and shakes” diet.

The meal plan consists of two shakes and one soup a day, containing all necessary nutrients.

The NHS said the trial’s “fantastic” results meant that it would expand the scheme across England in the next 12 months, after a test run showed that patients lost 12kg in three months, on average.

Ten per cent of the NHS budget, about £10 billion a year, is spent on diabetes, which can cause heart disease, stroke, nerve damage, blindness, and kidney failure.

The director of research at Diabetes UK, Dr Elizabeth Robertson, said, “For those that aren’t able to go into remission, losing weight can still lead to major health benefits, including improved blood-sugar levels and reduced risk of serious diabetes complications.”

More For You

Camellia Panjabi's cookbook elevates
vegetables from sides to stars

Camellia Panjabi (Photo: Ursula Sierek)

Camellia Panjabi's cookbook elevates vegetables from sides to stars

RESTAURATEUR and writer Camellia Panjabi puts the spotlight on vegetables in her new book, as she said they were never given the status of a “hero” in the way fish, chicken or prawns are.

Panjabi’s Vegetables: The Indian Way features more than 120 recipes, with notes on nutrition, Ayurvedic insights and cooking methods that support digestion.

Keep ReadingShow less
Spotting the signs of dementia

Priya Mulji with her father

Spotting the signs of dementia

How noticing the changes in my father taught me the importance of early action, patience, and love

I don’t understand people who don’t talk or see their parents often. Unless they have done something to ruin your lives or you had a traumatic childhood, there is no reason you shouldn’t be checking in with them at least every few days if you don’t live with them.

Keep ReadingShow less
HH Guruji performed the Dhwaja Ritual at Ambaji Temple

HH Guruji performed the Dhwaja Ritual at Ambaji Temple

Mahesh Liloriya

The holy town of Ambaji witnessed a spiritually significant day on Sunday as His Holiness Siri Rajrajeshwar Guruji, head of the International Siddhashram Shakti Centre, London, performed the Dhwaja ritual at the historic Ambaji Temple in Gujarat, one of the most revered Shakti Peeths of India.

Keep ReadingShow less
Eco-friendly Ganesh Utsav at Harrow’s Siddhashram Shakti Centre

Eco-friendly Ganesh Utsav at Harrow’s Siddhashram Shakti Centre

Mahesh Liloriya

The International Siddhashram Shakti Centre in Harrow witnessed an inspiring and environmentally responsible celebration of Ganesh Utsav 2025, which concluded on Saturday, 6 September, with the Ganesh Visarjan ritual performed on the sacred occasion of Anant Chaturdashi.

Keep ReadingShow less
Mounjaro price rise

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro

iStock

Mounjaro’s highest dose to rise from £122 to £247.50, not £330

Highlights:

  • Eli Lilly had announced a steep price rise of up to 170% for Mounjaro.
  • A new discount deal with UK suppliers will limit the increase for patients.
  • Pharmacies will still apply a mark-up, but consumer costs are expected to rise less than initially feared.
  • NHS pricing remains unaffected due to separate arrangements.

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro, easing fears of a sharp rise in costs for UK patients. The new arrangement means that, from September, pharmacies and private services will face smaller wholesale increases than first expected, limiting the impact on consumers.

Why the price rise was announced

Earlier this month, Eli Lilly said it would raise Mounjaro’s list price by as much as 170%, which could have pushed the highest monthly dose from £122 to £330. The company argued that UK pricing needed to align more closely with higher costs in Europe and the United States.

Keep ReadingShow less